Molecular BiologyiSciencePeer-reviewed
Selective Modulator of Nuclear Receptor PPARy with Reduced Adipogenic Potential Ameliorates Experimental Nephrotic Syndrome
Claire Bryant, Galen C. Rask, Amanda P. Waller…·Shipra Agrawal
This study compares the effects of GQ-16, a PPARγ partial agonist, and pioglitazone, a PPARγ full agonist, in treating nephrotic syndrome in rats, finding that GQ-16 reduces proteinuria and co-morbidities with fewer adipogenic side effects.
5 citations